Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2018-2029)
2.2 Global Fragment-based Drug Discovery Growth Trends by Region
2.2.1 Fragment-based Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fragment-based Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2029)
2.3 Fragment-based Drug Discovery Market Dynamics
2.3.1 Fragment-based Drug Discovery Industry Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Fragment-based Drug Discovery by Players
3.1.1 Global Fragment-based Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fragment-based Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2022
3.5 Global Key Players of Fragment-based Drug Discovery Head office and Area Served
3.6 Global Key Players of Fragment-based Drug Discovery, Product and Application
3.7 Global Key Players of Fragment-based Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2029)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2018-2029)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2018-2023)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2024-2029)
6.2.3 North America Fragment-based Drug Discovery Market Share by Type (2018-2029)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2018-2023)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2024-2029)
6.3.3 North America Fragment-based Drug Discovery Market Share by Application (2018-2029)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2018-2023)
6.4.3 North America Fragment-based Drug Discovery Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2018-2029)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2018-2023)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2024-2029)
7.2.3 Europe Fragment-based Drug Discovery Market Share by Type (2018-2029)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2018-2023)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2024-2029)
7.3.3 Europe Fragment-based Drug Discovery Market Share by Application (2018-2029)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2018-2023)
7.4.3 Europe Fragment-based Drug Discovery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Fragment-based Drug Discovery Market Size (2018-2029)
8.2 China Fragment-based Drug Discovery Market Size by Type
8.2.1 China Fragment-based Drug Discovery Market Size by Type (2018-2023)
8.2.2 China Fragment-based Drug Discovery Market Size by Type (2024-2029)
8.2.3 China Fragment-based Drug Discovery Market Share by Type (2018-2029)
8.3 China Fragment-based Drug Discovery Market Size by Application
8.3.1 China Fragment-based Drug Discovery Market Size by Application (2018-2023)
8.3.2 China Fragment-based Drug Discovery Market Size by Application (2024-2029)
8.3.3 China Fragment-based Drug Discovery Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Fragment-based Drug Discovery Market Size (2018-2029)
9.2 Asia Fragment-based Drug Discovery Market Size by Type
9.2.1 Asia Fragment-based Drug Discovery Market Size by Type (2018-2023)
9.2.2 Asia Fragment-based Drug Discovery Market Size by Type (2024-2029)
9.2.3 Asia Fragment-based Drug Discovery Market Share by Type (2018-2029)
9.3 Asia Fragment-based Drug Discovery Market Size by Application
9.3.1 Asia Fragment-based Drug Discovery Market Size by Application (2018-2023)
9.3.2 Asia Fragment-based Drug Discovery Market Size by Application (2024-2029)
9.3.3 Asia Fragment-based Drug Discovery Market Share by Application (2018-2029)
9.4 Asia Fragment-based Drug Discovery Market Size by Region
9.4.1 Asia Fragment-based Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Fragment-based Drug Discovery Market Size by Region (2018-2023)
9.4.3 Asia Fragment-based Drug Discovery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.1.5 Astex Pharmaceuticals Recent Developments
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.2.5 Alveus Pharmaceuticals Recent Developments
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.3.5 Beactica Recent Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.4.5 Charles River Laboratories Recent Developments
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.5.5 Crown Bioscience Recent Developments
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.6.5 Emerald BioStructures Recent Developments
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.7.5 Evotec Recent Developments
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.8.5 Kinetic Discovery Recent Developments
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.9.5 Proteros Fragments Recent Developments
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.10.5 Sprint Bioscience Recent Developments
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.11.5 Structure Based Design Recent Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.12.5 Sygnature Discovery Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Fragment-based Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Region (2018-2023)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Region (2024-2029)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Revenue Share by Players (2018-2023)
Table 16. Global Top Fragment-based Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Table 17. Global Fragment-based Drug Discovery Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Fragment-based Drug Discovery, Headquarters and Area Served
Table 20. Global Key Players of Fragment-based Drug Discovery, Product and Application
Table 21. Global Key Players of Fragment-based Drug Discovery, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2018-2023)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2024-2029)
Table 27. Global Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Share by Application (2018-2023)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Share by Application (2024-2029)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Fragment-based Drug Discovery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Fragment-based Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 63. Astex Pharmaceuticals Company Details
Table 64. Astex Pharmaceuticals Business Overview
Table 65. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 66. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 67. Astex Pharmaceuticals Recent Developments
Table 68. Alveus Pharmaceuticals Company Details
Table 69. Alveus Pharmaceuticals Business Overview
Table 70. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 71. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 72. Alveus Pharmaceuticals Recent Developments
Table 73. Beactica Company Details
Table 74. Beactica Business Overview
Table 75. Beactica Fragment-based Drug Discovery Product
Table 76. Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 77. Beactica Recent Developments
Table 78. Charles River Laboratories Company Details
Table 79. Charles River Laboratories Business Overview
Table 80. Charles River Laboratories Fragment-based Drug Discovery Product
Table 81. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 82. Charles River Laboratories Recent Developments
Table 83. Crown Bioscience Company Details
Table 84. Crown Bioscience Business Overview
Table 85. Crown Bioscience Fragment-based Drug Discovery Product
Table 86. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 87. Crown Bioscience Recent Developments
Table 88. Emerald BioStructures Company Details
Table 89. Emerald BioStructures Business Overview
Table 90. Emerald BioStructures Fragment-based Drug Discovery Product
Table 91. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 92. Emerald BioStructures Recent Developments
Table 93. Evotec Company Details
Table 94. Evotec Business Overview
Table 95. Evotec Fragment-based Drug Discovery Product
Table 96. Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 97. Evotec Recent Developments
Table 98. Kinetic Discovery Company Details
Table 99. Kinetic Discovery Business Overview
Table 100. Kinetic Discovery Fragment-based Drug Discovery Product
Table 101. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 102. Kinetic Discovery Recent Developments
Table 103. Proteros Fragments Company Details
Table 104. Proteros Fragments Business Overview
Table 105. Proteros Fragments Fragment-based Drug Discovery Product
Table 106. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 107. Proteros Fragments Recent Developments
Table 108. Sprint Bioscience Company Details
Table 109. Sprint Bioscience Business Overview
Table 110. Sprint Bioscience Fragment-based Drug Discovery Product
Table 111. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 112. Sprint Bioscience Recent Developments
Table 113. Structure Based Design Company Details
Table 114. Structure Based Design Business Overview
Table 115. Structure Based Design Fragment-based Drug Discovery Product
Table 116. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 117. Structure Based Design Recent Developments
Table 118. Sygnature Discovery Company Details
Table 119. Sygnature Discovery Business Overview
Table 120. Sygnature Discovery Fragment-based Drug Discovery Product
Table 121. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 122. Sygnature Discovery Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Fragment-based Drug Discovery Market Share by Type: 2022 VS 2029
Figure 3. Fragment Screening Features
Figure 4. Fragment Optimization Features
Figure 5. Global Fragment-based Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Fragment-based Drug Discovery Market Share by Application: 2022 VS 2029
Figure 7. Academic and Research Institutions Case Studies
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Fragment-based Drug Discovery Report Years Considered
Figure 11. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Fragment-based Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Fragment-based Drug Discovery Market Share by Region: 2022 VS 2029
Figure 14. Global Fragment-based Drug Discovery Market Share by Players in 2022
Figure 15. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2022
Figure 17. North America Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 19. North America Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 20. North America Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 21. United States Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 25. Europe Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 26. Europe Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 27. Germany Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 35. China Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 36. Asia Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 38. Asia Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 39. Asia Fragment-based Drug Discovery Market Share by Region (2018-2029)
Figure 40. Japan Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 50. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 57. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 58. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 59. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 60. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 61. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 62. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 63. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 64. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 65. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 66. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 67. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed